Variation in hepatitis B immunization coverage rates associated with provider practices afer the temporary suspension of the birth dose

BMC Pediatrics

Volumn 6, Issue , 2006, Pages

  Lin, Nancy D ^a,b   Kleinman, Ken ^a   Chan, K Arnold ^c   Yu, Xian Jie ^a   France, Eric K ^d   Wei, Feifei ^e   Mullooly, John P ^f   Black, Steven ^g   Shay, David K ^h   Kolczak, Margarette ^h   Lieu, Tracy A ^a   Mode, Nicolle ^e,h   Butani, Amy ^e,h   Yamasaki, Kristi ^d,h   Smith Ray, Renae ^d,h   Carpenter, Diane ^g,h   Riedlinger, Karen ^d,h  

^a HARVARD MEDICAL SCHOOL   (United States)

^b STANFORD UNIVERSITY   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d KAISER PERMANENTE   (United States)

^e HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^f CENTER FOR HEALTH RESEARCH   (United States)

^g Vaccine Study Center   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ARTICLE; CHILD HEALTH CARE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEPATITIS B; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PROBABILITY; PUBLIC HEALTH SERVICE; RETROSPECTIVE STUDY; UNITED STATES;

COHORT STUDIES; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT, NEWBORN; RETROSPECTIVE STUDIES; VACCINATION;

EID: 33845286939     PISSN: 14712431     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-6-31     Document Type: Article

References (17)

1. Ball LK, Ball R, Pratt RD: An assessment of thimerosal use in childhood vaccines. Pediatrics 2001, 107(5):1147-1154.
2. Freed GL, Andreae MC, Cowan AE, Katz SL: The process of public policy formulation: the case of thimerosal in vaccines. Pediatrics 2002, 109(6):1153-1159.
3. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb Mortal Wkly Rep 1999, 48(26):563-565.
4. Availability of hepatitis B vaccine that does not contain thimerosal as a preservative. MMWR Morb Mortal Wkly Rep 1999, 48(35):780-782.
5. Yusuf HR, Daniels D, Smith P, Coronado V, Rodewald L: Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series. Jama 2000, 284(8):978-983.
6. Oram RJ, Daum RS, Seal JB, Lauderdale DS: Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine. Jama 2001, 285(14):1874-1879.
7. Clark SJ, Cabana MD, Malik T, Yusuf H, Freed GL: Hepatitis B vaccination practices in hospital newborn nurseries before and after changes in vaccination recommendations. Arch Pediatr Adolesc Med 2001, 155(8):915-920.
8. Hurie MB, Saari TN, Davis JP: Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices. Pediatrics 2001, 107(4):755-758.
9. Luman ET, Fiore AE, Strine TW, Barker LE: Impact of thimerosal-related changes in hepatitis B vaccine birth-dose recommendations on childhood vaccination coverage. Jama 2004, 291(19):2351-2358.
10. Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilak SG, Hadler SC: Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics 1997, 99(6):765-773.
11. Chen RT, DeStefano F, Davis RL, Jackson LA, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Ward JI, Marcy SM: The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull World Health Organ 2000, 78(2):186-194.
12. DeStefano F: The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Saf 2001, 10(5):403-406.
13. Recommended childhood immunization schedule - United States, 2002. MMWR Morb Mortal Wkly Rep 2002, 51(2):31-33.
14. Atkinson WL, Pickering LK, Schwartz B, Weniger BG, Iskander JK, Watson JC: General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Recomm Rep 2002, 51(RR-2):1-35.
15. Hinman AP, Orenstein WA, Santoli JM, Rodewald LE, Cochi SL: Vaccine shortages: history, impact, and prospects for the future. Annu Rev Public Health 2006, 27:235-259.
16. Stokley S, Santoli JM, Willis B, Kelley V, Vargas-Rosales A, Rodewald LE: Impact of vaccine shortages on immunization programs and providers. Am J Prev Med 2004, 26(1):15-21.
17. Santoli JM, Klein JO, Peter G, Orenstein WA: Disruptions in the supply of routinely recommended childhood vaccines in the United States. Pediatr Infect Dis J 2004, 23(6):553-554.